Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands

Syanni A. Kristalijn,Karen White,Deanna Eerbeek,Emilia Kostenko,Francesca Romana Grati,Caterina M. Bilardo
DOI: https://doi.org/10.1186/s12884-022-05110-2
2022-10-22
BMC Pregnancy and Childbirth
Abstract:Non-invasive prenatal testing (NIPT) as a screening method for trisomy 21 and other chromosomal abnormalities has been adopted widely across the globe. However, while many clinical validation studies have been performed, less is known regarding the patient experience with NIPT. This study explored how individuals experience NIPT in a pre- and post-test setting, where NIPT is broadly available as a primary screening method with the option of reporting beyond common trisomies.
obstetrics & gynecology
What problem does this paper attempt to address?